DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Cash and Bank History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash and Bank | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr | ₹2,156 Cr | ₹123 Cr |
What is the latest Cash and Bank ratio of DIVIS LABORATORIES ?
Year | Cash and Bank |
---|---|
Mar2024 | ₹3,980 Cr |
Mar2023 | ₹4,214 Cr |
Mar2022 | ₹2,819 Cr |
Mar2021 | ₹2,156 Cr |
Mar2020 | ₹123 Cr |
How is Cash and Bank of DIVIS LABORATORIES Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2024 | ₹3,980 Cr | -5.55 | |
Mar2023 | ₹4,214 Cr | 49.49 | |
Mar2022 | ₹2,819 Cr | 30.74 | |
Mar2021 | ₹2,156 Cr | 1,658.16 | |
Mar2020 | ₹123 Cr | - |
Compare Cash and Bank of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹144,316.5 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,025.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics | |
MANKIND PHARMA | ₹97,396.6 Cr | -2.7% | 6.6% | 33.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -1.1% |
11% |
43.2% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses